SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery

Condition(s) studied

Investigational drug(s) / intervention(s)

SPS block: 30 mL of 0.25% Bupivacaine will be injected into the plane between the Serratus Posterior Superior muscle and the intercostal muscles at the scapular level.

Surgical Intercostal Blockade.: At the end of the operation, the surgeon will perform an injection of a total of 30 mL of 0.25% Bupivacaine into three intercostal nerves above and below the incision site under direct thoracoscopic visualization.

Study summary

This study aims to evaluate the efficacy of ultrasound-guided Serratus Posterior Superior (SPS) block compared to surgeon-administered intercostal blockade in preventing chronic pain at 3, 6, and 12 months following Video-Assisted Thoracoscopic Surgery (VATS).

Eligibility

Primary outcome measure(s)

• Incidence and severity of Chronic Post-Thoracotomy Pain (CPTP) — Incidence and severity of Chronic Post-Thoracotomy Pain (CPTP) at 3, 6, and 12 months post-surgery.
  The primary aim is to compare incidence and severity of Chronic Post-Thoracotomy Pain with McGill Pain Questionnaire (MPQ).

Trial sites (1)

More Medipol University trials in Turkey

Other trials for the same condition